全文获取类型
收费全文 | 98120篇 |
免费 | 6550篇 |
国内免费 | 4128篇 |
专业分类
耳鼻咽喉 | 2118篇 |
儿科学 | 920篇 |
妇产科学 | 2494篇 |
基础医学 | 6324篇 |
口腔科学 | 566篇 |
临床医学 | 10838篇 |
内科学 | 7466篇 |
皮肤病学 | 361篇 |
神经病学 | 7071篇 |
特种医学 | 7129篇 |
外国民族医学 | 52篇 |
外科学 | 16611篇 |
综合类 | 15581篇 |
现状与发展 | 3篇 |
预防医学 | 2650篇 |
眼科学 | 265篇 |
药学 | 5303篇 |
11篇 | |
中国医学 | 619篇 |
肿瘤学 | 22416篇 |
出版年
2024年 | 183篇 |
2023年 | 877篇 |
2022年 | 1957篇 |
2021年 | 2500篇 |
2020年 | 2315篇 |
2019年 | 2010篇 |
2018年 | 1930篇 |
2017年 | 2431篇 |
2016年 | 3097篇 |
2015年 | 2687篇 |
2014年 | 5363篇 |
2013年 | 4949篇 |
2012年 | 6038篇 |
2011年 | 6727篇 |
2010年 | 5966篇 |
2009年 | 5818篇 |
2008年 | 5749篇 |
2007年 | 6211篇 |
2006年 | 5882篇 |
2005年 | 5615篇 |
2004年 | 4379篇 |
2003年 | 3882篇 |
2002年 | 3219篇 |
2001年 | 3157篇 |
2000年 | 2615篇 |
1999年 | 2017篇 |
1998年 | 1753篇 |
1997年 | 1602篇 |
1996年 | 1063篇 |
1995年 | 967篇 |
1994年 | 829篇 |
1993年 | 537篇 |
1992年 | 517篇 |
1991年 | 425篇 |
1990年 | 399篇 |
1989年 | 320篇 |
1988年 | 322篇 |
1987年 | 318篇 |
1986年 | 265篇 |
1985年 | 263篇 |
1984年 | 211篇 |
1983年 | 136篇 |
1982年 | 176篇 |
1981年 | 150篇 |
1980年 | 145篇 |
1979年 | 132篇 |
1978年 | 105篇 |
1977年 | 112篇 |
1976年 | 99篇 |
1973年 | 85篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
81.
1976~1986年肿瘤科收治脑胶质瘤42例,10例复发,其中6例采用单纯放疗,用~60钴γ线。5例脑胶质瘤予肿瘤区局部照射,DT44~57Gy/6-7周,1例髓母细胞瘤予全脑、肿瘤区及全脊髓照射、脑中平面量DT38Gy/5周;肿瘤区51Gy/7周;脊髓18Gy/8周。结果:有效1例,显效2例,无效3例。本研究提示对于已不能釆用其他手段治疗的复发病人,放疗仍有一定效果。 相似文献
82.
Inflammatory central nervous system disease in lupus-prone MRL/lpr mice: comparative histologic and immunohistochemical findings 总被引:7,自引:0,他引:7
Catherine M. Vogelweid Gayle C. Johnson Cynthia L. Besch-Williford Joe Basler Sara E. Walker 《Journal of neuroimmunology》1991,35(1-3):89-99
The brains of pathogen-free autoimmune MRL/lpr, NZBWF1 and NZB mice were examined for central nervous system (CNS) inflammation in premoribund 8-week-old animals and at ages when active systemic lupus erythematosus (SLE) was present. CNS inflammation was observed only in MRL/lpr mice. Immunohistochemical studies of brains from young MRL/lpr mice found that infiltrates were composed primarily of CD4+ cells. Older MRL/lpr mice (22 and 26 weeks of age) had CD4+ cells predominantly, but CD8+ and B220+ cells were also present. Perivascular leakage of IgG was a prominent and unexpected finding in the MRL/lpr model. Congenic MRL/+ mice with late-onset autoimmunity had no inflammatory cells in brain tissue, and there was no perivascular staining with IgG or albumin. Our findings suggest that MRL/lpr mice are a useful model for studies of lupus-associated CNS inflammatory disease, and perivascular leakage may be a primary mechanism for entry of IgG into the brain. 相似文献
83.
The firing rate of locus coeruleus (LC) neurons in rat brain slices was increased reversibly by agents that either elevate intracellular levels of adenosine 3',5'-cyclic monophosphate (cAMP) or mimic its actions (e.g., forskolin, and activator of adenylate cyclase, 8-Br-cAMP, a membrane permeable analog of cAMP, and Ro20-1724, a preferential inhibitor of cAMP-phosphodiesterase). Intracellular recordings showed that 8-Br-cAMP and forskolin induce a depolarization of LC neurons, accompanied by a decrease in input resistance. The 8-Br-cAMP- and forskolin-elicited depolarization persisted in the presence of cobalt, a calcium channel blocker. Steady-state current-voltage curves revealed that in the voltage range of -50 to -120 mV, 8-Br-cAMP and forskolin induced an inward current, which did not reverse at the potassium equilibrium potential and could not be blocked by tetrodotoxin. Partial replacement of sodium with Tris or choline markedly reduced the depolarization elicited by 8-Br-cAMP. We conclude that 8-Br-cAMP and forskolin act through a common mechanism to increase the firing rate of locus coeruleus neurons by inducing a cAMP-activated inward current, carried out at least in part by sodium ions. 相似文献
84.
多希紫杉醇联合顺铂治疗晚期非小细胞肺癌疗效观察 总被引:1,自引:0,他引:1
目的观察和评价多希紫杉醇联合顺铂(DP方案)治疗晚期非小细胞肺癌的疗效和毒性。方法将我科近几年收治的48例晚期非小细胞肺癌患者随机分为治疗组和对照组。治疗组采用多希紫杉醇联合顺铂(DP方案),对照组采用长春瑞滨联合顺铂(NP方案)。2周期化疗后进行疗效、毒性对比研究。结果治疗组和对照组近期有效率分别为45.5%和37.5%,疾病进展时间(TTP)分别为6.3和5.9个月,中位生存期分别为10.1和9.0个月,1年生存率分别为45.8%和39.4%,两组间比较差异均无显著性(P>0.05)。治疗组在恶心呕吐、骨髓抑制等毒性反应发生率方面低于对照组,差异有显著性(P<0.05)。结论多希紫杉醇联合顺铂治疗晚期非小细胞肺癌与NP方案相比较,疗效相似,但毒性反应低于NP组,患者更易耐受,可广泛应用于临床。 相似文献
85.
耳源性脑疝25例,抢救成功者19例。采用单纯脑脓肿穿刺抽脓抢救脑疝6例,仅1例成功;开颅减压术抢救脑疝20例,18例抢救成功。本组临床实践和文献报道都说明耳源性脑疝一旦发生应即刻行开颅减压术,能卓有成效地抢救生命 相似文献
86.
Introduction Hypothalamic hamartomas are congenital malformations. Clinically, they can be asymptomatic, but they cause seizures, mental
retardation and precocious puberty in many cases.
Case report A 20-day-old boy with hypothalamic hamartoma and bilateral anophthalmia was presented. Except those, no other congenital anomaly
was detected.
Conclusion This is a rare case of hypothalamic hamartoma with bilateral anophthalmia. The mutations at SOX2 has an important role in
the developing brain and eyes. 相似文献
87.
目的 :评价原发性肝癌并发门静脉高压症的外科治疗效果。方法 :回顾性分析联合手术治疗原发性肝癌并发门静脉高压症 30例的疗效。结果 :手术死亡 1例 ,严重肺部感染、肝肾综合征及顽固性腹水各 1例。术后 1、3、5年生存率分别为 93.3%、5 3.3%、40 %。随访中共死亡 1 7例 ,死亡原因 :肝癌复发 9例 ,肝功能衰竭 5例 ,上消化道出血 3例。结论 :理性选择联合手术方式治疗原发性肝癌并发门静脉高压症是安全可行的 ,联合行胃冠状静脉栓塞和脾切除术效果良好。 相似文献
88.
低剂量奥沙利铂并氟脲嘧啶对晚期复发直肠癌放疗增敏作用的临床观察 总被引:2,自引:0,他引:2
目的:观察奥沙利铂(L-OHP)并5-氟脲嘧啶、甲酰四氢叶酸钙(5-Fu/LV)配合放疗治疗晚期复发直肠癌患者的增效作用与毒性反应。方法:23例无法手术的晚期复发直肠癌患者进行盆腔放疗,在放疗的第1、5同前一天开始给予L-OHP30mg/m。静滴0.5h,LV100mg/m^2和5-Fu375mg/m^2静滴4h,连用4d。25例单纯放疗者为对照组。结果:放疗结束时,观察组局部症状缓解率较对照组高,尤其对会阴区下坠疼的改善明显(P〈0.05),且转移症状亦有所缓解。两组有效率分别为78.3%、48%(P〈0.05),完全缓解分别为8.7%、4.0%。主要毒副反应是消化道反应、神经毒性、静脉炎,骨髓抑制。结论:利用低剂量L-OHP并5-Fu/LV的增敏作用配合放疗治疗晚期、复发直肠癌可提高近期疗效,改善症状,尤其对于伴远外转移者,为理想、安全的治疗手段。 相似文献
89.
目的 总结32例前列腺癌患者新辅助治疗(NHT)的作用。方法 32例前列腺癌患者中药物去势17例,手术去势15例,并联合抗雄激素治疗3个月,统计NHT前后前列腺癌体积、肿瘤大小、PSA、FSH、LH和睾酮水平变化。结果 2组NHT后前列腺体积明显变小、肿瘤变小、变软,甚至消失,PSA和睾酮明显下降,药物去势组睾酮水平在耻骨后前列腺癌根治术(RRP)术后2~3个月可恢复正常,而手术去势组RRP术后睾酮呈持续低水平。结论 NHT可明显缩小前列腺体积,降低PSA,有利于手术操作。药物去势对内分泌影响是可逆的,而手术去势内分泌改变不可逆。 相似文献
90.
L. M. Ramondetta G. Tortolero-Luna D. C. Bodurka D. Sills† K. Basen-Engquist‡ J. Gano & C. Levenback 《International journal of gynecological cancer》2004,14(4):580-588
We sought to explore the Society of Gynecologic Oncologists (SGO) members' opinions and decisions about end-of-life issues and incurable conditions. A survey was mailed to members of the SGO. Their responses were recorded on a Likert scale and entered into a database. The survey explored opinions, experiences, and decisions in managing terminally ill gynecologic oncology patients. Of 900 surveys, 327 were returned (response rate, 36%). Seventy-three percent were men, 89% were white, and 72% were of Christian denomination. Respondents believed that 97% of patients who are dying realize that they are dying but stated only 40% of these patients initiate conversations about end-of-life issues. In contrast, 92% of respondents stated that they initiate end-of-life discussions with patients. Ninety-two percent of respondents thought that the patients should be allowed to make end-of-life choices independently after the facts are given to them. However, 44% thought that it is important to influence the way information is presented, and 54% believe that the gynecologic oncologist (GO) controls the outcome of end-of-life discussions. Although the physicians' sex, race, religion, and age did not correlate with their treatment decisions, religion did correlate with less fear of death (P = 0.011) and less discomfort when talking with patients about death (P = 0.005). Fifty-four percent of respondents believed that the GO controls the outcome of end-of-life discussions, and 40% believe that their actions prolong the process of dying. Expanding our understanding of what motivates GOs to recommend continued treatment over palliation is important for preserving informed patient-motivated end-of-life decisions. 相似文献